Clinical trial

Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors

NCT00003038

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date1997-10-01

PhasePHASE1

Study timeline

Study start (unknown)1997-10-01Date precision: month

Registry last updated2011-08-03

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Adrenocortical Carcinomaunresolved

Breast Cancerunresolved

Colorectal Cancerunresolved

Prostate Cancerunresolved

Unspecified Adult Solid Tumor, Protocol Specificunresolved

Interventions

doxorubicin hydrochlorideDRUG · verified · RxNorm: doxorubicin hydrochloride

Sponsors & collaborators

Mayo Cliniclead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

RochesterMinnesota, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00003038 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.